New hope for seniors: targeted chemo may beat standard treatment for advanced colorectal cancer
NCT ID NCT07209384
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether delivering chemotherapy directly to the liver (transarterial chemoembolization) works better and causes fewer side effects than standard IV chemotherapy in people aged 65 and older with advanced colorectal cancer that cannot be removed by surgery. About 50 participants will receive either the targeted approach or standard treatment, with or without additional targeted drugs. The goal is to see if the targeted method shrinks tumors more effectively and controls the disease longer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Playing in the sand: a creative path to brighter golden years?
- Cartoon workouts may help seniors beat fear of falling
- New drug combo aims to boost immune attack on Hard-to-Treat cancers
- New oxygen sensor could give earlier warning for elderly and obese patients under anesthesia
- Can education and exercise help older adults fight muscle loss?
- New drug combo shows promise for tough cancers